Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…citinib or upadacitinib), rituximab, tocilizumab, methotrexate, mycophenolate mofetil, or glucocorticoids (>=10 mg prednisone equivalent daily) for m…
…slowing lung function decline in lcSSc. In addition, a trial of tofacitinib with 40 (61%) lcSSc patients showed that this drug was more eff…
…erapy. Three patients with poor prognostic factors treated with rituximab had a surprisingly good outcome.Interestingly, three patients d…
…of RTX (cumulative dose of 8 g). The pts were also treated with mycophenolate mofetil 2000 mg/day continuously for the last 8 and 7 years, respective…
… plus rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone, he had achieved a complete metabolic response by positron-emis…
… diffuse large B-cell lymphoma (DLBCL) who completed first-line rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone or ritu…
…een put forward for consideration in treating high-risk TA-TMA; eculizumab, narsopilmab, rituximab, defibrotide, ravulizumab, nomacopan, p…
… eligible-ASCT)YesGO29365:Multicentre/open-label/phase Ib/II vs.Rituximab/bendamustine2A (OS improvement)Improved mPFS by 5.8 mo(HR=0.36)…
…d HCQ 400 mg/day. In August 2025, due to inadequate efficacy of rituximab (3 g), intolerance to MMF, and limitations on IS (due to leukop…
…thematous (SLE). We report a case of recurrent ALP treated with anifrolumab.Methods A 47-year-old man presented in August 2022 with progres…
…ar necrosis of both femoral heads. Current medications included mycophenolate mofetil, methylprednisolone, nifedipine, bosentan, and aspirin, along w…
… immunomodulation with combination targeted biologics—including eculizumab—may achieve full end-organ recovery despite life-threatening im…